Julie E Lang

Summary

Affiliation: University of Arizona
Country: USA

Publications

  1. pmc Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review
    Rebecca L Klein
    1 Department of Surgery, Section of Surgical Oncology, The University of Arizona Cancer Center Tucson, Arizona, USA
    J Cancer 1:27-31. 2010
  2. pmc Complications of methylene blue dye in breast surgery: case reports and review of the literature
    Fj Reyes
    1 Department of General Surgery, Division of Surgical Oncology, University of Arizona, Tucson, AZ 85724, USA
    J Cancer 2:20-5. 2010
  3. pmc Radiation-induced sarcoma of the breast: a systematic review
    Grishma R Sheth
    Department of Surgery, Division of Surgical Oncology, University of Arizona, 1501 N Campbell Avenue, Room 4327, P O Box 245131, Tucson, Arizona 85724, USA
    Oncologist 17:405-18. 2012
  4. pmc A comparison of RNA amplification techniques at sub-nanogram input concentration
    Julie E Lang
    Department of Surgery, UCSF Comprehensive Cancer Center, 1500 Divisadero Street, San Francisco, CA 94143, USA
    BMC Genomics 10:326. 2009
  5. ncbi request reprint Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Julie E Lang
    The University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, Unit 444, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Expert Rev Anticancer Ther 7:1463-72. 2007
  6. pmc EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low
    Alexander Ring
    Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
    Oncotarget 6:44623-34. 2015
  7. pmc Expression profiling of circulating tumor cells in metastatic breast cancer
    Julie E Lang
    Division of Breast and Soft Tissue Surgery, Department of Surgery, Norris Comprehensive Cancer Center NCCC, University of Southern California USC, 1510 San Pablo Street Suite 412, Los Angeles, CA, 90033 0800, USA
    Breast Cancer Res Treat 149:121-31. 2015
  8. doi request reprint Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer
    Julie E Lang
    Department of Surgery and UCSF Comprehensive Cancer Center, UCSF, San Francisco, CA 94143 1674, USA
    Breast J 15:242-6. 2009
  9. doi request reprint Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer?
    Liang Chih Liu
    Department of Surgery and Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA
    J Am Coll Surg 207:853-8. 2008
  10. ncbi request reprint Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation
    Julie E Lang
    Department of Surgery, University of California San Francisco, San Francisco, CA 94114, USA
    J Am Coll Surg 199:856-62. 2004

Collaborators

  • L J Esserman
  • Stanley P Leong
  • Ying Lu
  • G Mike Makrigiorgos
  • John W Park
  • Hope S Rugo
  • Anthony Lucci
  • E Shelley Hwang
  • Alexander Ring
  • Grishma R Sheth
  • Lauren Grasso-Lebeau
  • Fj Reyes
  • Rebecca L Klein
  • Liang Chih Liu
  • Min Yu
  • Debu Tripathy
  • Emily Park
  • Tania Porras
  • Vasu Punj
  • Dany Barrak
  • Neal Mineyev
  • Weizhu Zhu
  • Chip Lomas
  • Victoria Forte
  • Benjamin D Smith
  • Lee D Cranmer
  • Christian M Gomez-Castro
  • Janiel M Cragun
  • Mb Noelck
  • L Grasso-Lebeau
  • Setsuko K Chambers
  • C Valentino
  • Amanda R Brown
  • Eugene Morita
  • Michael Alvarado
  • Shelley E Hwang
  • Tyler Jenkins
  • Patrick Treseler
  • Shima Sokol
  • Cheryl A Ewing

Detail Information

Publications10

  1. pmc Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review
    Rebecca L Klein
    1 Department of Surgery, Section of Surgical Oncology, The University of Arizona Cancer Center Tucson, Arizona, USA
    J Cancer 1:27-31. 2010
    ..Ovarian metastasis to the breast confers a poor prognosis: patient survival ranged from 3 to 18 months, with a median survival of 6 months after the diagnosis of the breast metastasis...
  2. pmc Complications of methylene blue dye in breast surgery: case reports and review of the literature
    Fj Reyes
    1 Department of General Surgery, Division of Surgical Oncology, University of Arizona, Tucson, AZ 85724, USA
    J Cancer 2:20-5. 2010
    ..In each case severe necrosis and infection were present. Methylene blue may cause not only significant morbidity, but may also produce cosmetically unsatisfactory results...
  3. pmc Radiation-induced sarcoma of the breast: a systematic review
    Grishma R Sheth
    Department of Surgery, Division of Surgical Oncology, University of Arizona, 1501 N Campbell Avenue, Room 4327, P O Box 245131, Tucson, Arizona 85724, USA
    Oncologist 17:405-18. 2012
    ..Breast cancer survivors treated with radiotherapy constitute a large fraction of RIS patients. To evaluate evidenced-based practices for RIS treatment, we performed a systematic review of the published English-language literature...
  4. pmc A comparison of RNA amplification techniques at sub-nanogram input concentration
    Julie E Lang
    Department of Surgery, UCSF Comprehensive Cancer Center, 1500 Divisadero Street, San Francisco, CA 94143, USA
    BMC Genomics 10:326. 2009
    ..Microarray data from each amplification method were validated against quantitative real-time PCR (QPCR) for 37 genes...
  5. ncbi request reprint Significance of micrometastasis in bone marrow and blood of operable breast cancer patients: research tool or clinical application?
    Julie E Lang
    The University of Texas MD Anderson Cancer Center, Department of Surgical Oncology, Unit 444, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Expert Rev Anticancer Ther 7:1463-72. 2007
    ..The purpose of this report is to review the data regarding CTCs and DTCs in patients with operable breast cancer...
  6. pmc EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low
    Alexander Ring
    Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
    Oncotarget 6:44623-34. 2015
    ..The potential utility of circulating tumor cells (CTCs) as liquid biopsies is of great interest. We hypothesized that CTC capture using EpCAM based gating is feasible for most breast cancer subtypes...
  7. pmc Expression profiling of circulating tumor cells in metastatic breast cancer
    Julie E Lang
    Division of Breast and Soft Tissue Surgery, Department of Surgery, Norris Comprehensive Cancer Center NCCC, University of Southern California USC, 1510 San Pablo Street Suite 412, Los Angeles, CA, 90033 0800, USA
    Breast Cancer Res Treat 149:121-31. 2015
    ..Our approach may inform the discovery of therapeutic predictors and be useful for real-time identification of emerging resistance mechanisms in MBC patients...
  8. doi request reprint Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer
    Julie E Lang
    Department of Surgery and UCSF Comprehensive Cancer Center, UCSF, San Francisco, CA 94143 1674, USA
    Breast J 15:242-6. 2009
    ..57), or overall survival (p = 0.70). Positive non-SLNs removed during SSL are not a significant risk factor for additional positive nodes on completion axillary nodal dissection (CALND) or for worse survival than positive SLNs...
  9. doi request reprint Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer?
    Liang Chih Liu
    Department of Surgery and Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA
    J Am Coll Surg 207:853-8. 2008
    ..We hypothesized that the node with the highest radioactivity would have the strongest probability of being a positive SLN, and we sought to determine the lowest radioactive count of a node harboring cancer...
  10. ncbi request reprint Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation
    Julie E Lang
    Department of Surgery, University of California San Francisco, San Francisco, CA 94114, USA
    J Am Coll Surg 199:856-62. 2004
    ..It is important to determine whether SSL can be used after neoadjuvant chemotherapy and whether clinical node status at presentation affects accuracy of SSL...